Could a nebulizer beat an inhaler for COPD symptom relief?

NCT ID NCT07133880

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This trial asks whether giving COPD medication through a nebulizer works better than a dry powder inhaler. It enrolls adults over 40 with COPD symptoms and significant air trapping. Participants receive either a nebulizer or inhaler treatment, and researchers compare changes in lung volume and symptom scores. The goal is to see if one delivery method improves breathing and quality of life more than the other.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Long-acting bronchodilators (LAMA/LABA combination) delivered via nebulizer or dry powder inhaler
What this could lead to
If nebulizers prove better, it could guide COPD treatment choices, improving symptom relief and lung function for patients who struggle with inhalers.
What could go wrong
This is a phase 4 trial with 72 participants, so results may not apply to all COPD patients. Individual responses vary, and the study may not show a clear difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Tennessee Graduate School of Medicine

    RECRUITING

    Knoxville, Tennessee, 37920, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.